Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "herceptin"

High Court order not to affect product portfolio, says Biocon
DNA

High Court order not to affect product portfolio, says Biocon

Delhi High Court had prevented Biocon from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin. DNA, 1 week ago
Diagnostic & Invasive Cardiology

Heart Monitoring Suggested for All Breast Cancer Patients Undergoing Herceptin Treatment

— Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored for heart damage regardless of age. This is among the findings of a new study from the Peter Munk Cardiac Centre, the Institute for Clinical ...
 Diagnostic & Invasive Cardiology5 days ago Researchers suggest all breast cancer patients being treated with the drug trastuzumab, sold as Herceptin, are at higher risk for heart damage than thought.  TickerTech.com2 weeks ago Herceptin drugs for breast cancerlinked with increased risk of congestive heart failure  News-Medical.Net2 weeks ago Breast cancer patients receiving Herceptin treatment should be monitored for heart damage at any age  Science Daily1 week ago
[x]  
UPI

Breast cancer drug Herceptin increases heart damage risk, study says

TORONTO, April 20 (UPI) -- Although doctors already monitor older breast cancer patients for heart damage if their treatment includes the drug trastuzumab, researchers suggest all patients on the drug should be monitored based on the results of a ...
 UPI2 weeks ago
Witbank News

Breast cancer drug price prevents access for women in SA

Many women in South Africa who need breast cancer drug trastuzumab (marketed as Herceptin in SA) cannot access it due to the high price charged. Members of the Fix the Patent Laws campaign picketed outside pharmaceutical company Roche on 31 March to ...
 Witbank News4 weeks ago "I think I'm going to die," SA patient desperate for cancer drug tells UN  Mail & Guardian Online1 month ago

Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Revision: 28, Authorised

This is a summary of the European public assessment report (EPAR) for Herceptin. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency1 month ago
BioPharma-Reporter.com

Delhi HC strikes down breast cancer biosimilars' approval for Roche drug

In India, Trastuzumab is sold by Roche under the brand names Herceptin, Herclon and Biceltis
 Business Standard1 week ago Biocad ships Herceptin biosimilar to Sri Lanka  BioPharma-Reporter.com1 month ago
[x]  
India Infoline

Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs

Justice Manmohan Singh made it clear that these companies would not call their product "bio similar" to 'Herceptin, Herclon, Biceltis', the brand names of products by firm Roche Products (India) Pvt Ltd. The Delhi High Court has allowed Biocon Ltd and Mylan ...
 India Infoline1 week ago BIOCON : Delhi High Court permits Biocon, Mylan to carry on trade of Cancer drugs  4 Traders6 days ago PTI - HC-DRUGS - HC allows Biocon, Mylan to continue manufacturing cancer drugs  Namibia Press Agency1 week ago Delhi High Court allows Indian biopharma companies to manufacture cheaper anti-cancer drugs  International Business Times India1 week ago
[x]  

Roche's Q1 2016 Earnings Support Our Bullish Stance

Key Takeaways From Roche's Q1 2016 Earnings Cancer Behemoths Avastin, Herceptin & Rituxan Are Still Growing New Cancer Drugs Have Significant Growth Potential Drug Pipeline Is Looking Interesting Overall, Earnings Results Re-Affirm Our Bullish ...
 Trefis1 week ago Corcept Therapeutics' (CORT) CEO Joe Belanoff on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha12 hours ago Roche Holding's (RHHBY) CEO Severin Schwan on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha2 weeks ago Roche CEO Schwan beats Novartis chief with $12.3M in 2015 pay, but U.S. companies shell out more  FiercePharma1 month ago
All4Women

Herceptin and the cost of cancer

With breast cancer on the increase and Herceptin being lauded as the super expensive cure-all, is the cost cancer in South Africa spiralling out of control. But why is it so expensive and how effective is it .... AUTHOR INFO: Serisha Singh ...
 All4Women1 day ago
Times of India

HC nod to desi cos' version of cancer drug, but with curbs

The Delhi high court on Monday allowed the sale and manufacture of biosimilar versions of Roche's breast cancer drug Herceptin by Biocon and Reliance Life Sciences, reported The Times of India. However, the products will need to follow "strict" ...
 FirstWord Pharma1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - herceptin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less